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Background: QSAR is an established and powerful method for cheap in silico assessment of physicochemical
properties and biological activities of chemical compounds. However, QSAR models are rather complex
mathematical constructs that cannot easily be interpreted. Medicinal chemists would benefit from practical
guidance regarding which molecules to synthesize.
Another possible approach is analysis of pairs of very similar molecules, so-called matched molecular pairs (MMPs).
Such an approach allows identification of molecular transformations that affect particular activities (e.g. toxicity).
In contrast to QSAR, chemical interpretation of these transformations is straightforward. Furthermore, such transformations
can give medicinal chemists useful hints for the hit-to-lead optimization process.
Results: The current study suggests a combination of QSAR and MMP approaches by finding MMP transformations
based on QSAR predictions for large chemical datasets. The study shows that such an approach, referred to as
prediction-driven MMP analysis, is a useful tool for medicinal chemists, allowing identification of large numbers of
“interesting” transformations that can be used to drive the molecular optimization process. All the methodological
developments have been implemented as software products available online as part of OCHEM (http://ochem.eu/).
Conclusions: The prediction-driven MMPs methodology was exemplified by two use cases: modelling of aquatic
toxicity and CYP3A4 inhibition. This approach helped us to interpret QSAR models and allowed identification of a
number of “significant” molecular transformations that affect the desired properties. This can facilitate drug design as a
part of molecular optimization process.
Keywords: MMP, Matched molecular pairs, QSAR, Interpretation, Molecule optimization, Medicinal chemistry, Inverse
QSAR, OCHEM, Online chemical modelling environmentBackground
Quantitative Structure Activity Relationships (QSAR)
have proven to be a powerful technique for prediction of
biological activities and physicochemical properties.
QSAR models can be helpful in drug design, ecological
hazard assessment and in the chemical industry. The
properties predicted by QSARs vary from solubility and
melting point to toxicity, biological potency and possible
side effects [1-3].* Correspondence: yura.sushko@gmail.com
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unless otherwise stated.One of the issues with QSAR models is their poor in-
terpretability. While interpretation of simple linear re-
gressions can be straightforward, the most powerful
algorithms like neural networks are similar to “black
boxes”, which provide predictions that cannot be easily
interpreted. This undermines trust in such predictions
and prevents the creation of an “action plan” by a deci-
sion maker, for example a medicinal chemist. If a com-
pound is predicted to be toxic, what are the causal
factors for its toxicity? How can it be made non-toxic?
Such “black-box” model types are poorly suited to address
these crucial practical questions.
The QSAR interpretation problem has not escaped
the notice of regulatory bodies. Thus, “mechanistics an Open Access article distributed under the terms of the Creative Commons
org/licenses/by/4.0), which permits unrestricted use, distribution, and
riginal work is properly credited. The Creative Commons Public Domain
rg/publicdomain/zero/1.0/) applies to the data made available in this article,
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for acceptable QSAR predictive models for regulatory
purposes [4].
A recently suggested approach for the analysis of
chemical datasets uses pairs of compounds that differ by
a small single point change only. Such pairs are referred
to as matched molecular pairs or MMPs [5,6]. An ana-
lytical approach that deals with MMPs is matched mo-
lecular pairs analysis (MMPA). A number of MMPs are
given as examples in Figure 1.
Analysis of pairs of molecules with only minor local-
ized differences can be very useful for understanding the
mechanism of action. A significant change of activity fol-
lowing only a minor structural modification (known as an
“activity cliff”) can give additional insight (see Figure 2).
Furthermore, using simple statistical analysis molecular
pairs can be grouped by transformations, allowing the
identification of transformations that affect properties of
interest.
In the scientific literature [7], MMP analysis has fo-
cused mostly on analysis of experimental data and on
trying to identify rules that affect activities of interest.
Such analyses are not directly related to QSAR model-
ling, representing rather a complementary approach.
The current study aims to merge the worlds of QSAR-
and MMP-based analysis by introducing the concept of
prediction-driven MMPs.
MMP analysis has a practical goal: molecular transfor-
mations can help medicinal chemists to drive the mo-
lecular optimization process. This task is not directly
achievable through plain QSAR analysis. A QSAR model
provides predictions but does not explicitly identify how
a structure should be changed in order to achieve
the desired improvements (such as reducing toxicity,
enhancing activity or improving the ADME profile). ThisFigure 1 Four typical examples of matched molecular pairs (MMPs).problem is sometimes referred as inverse QSAR. This
study investigates how prediction-driven MMP rules can
guide the molecular optimization process.
The study is not limited to theoretical developments.
We also provide software implementation of all the analyt-
ical utilities – including identification of MMPs, statistical
analysis, visualization and interpretation utilities – and
tight integration with the database of experimental data
and a QSAR modelling framework. This study represents
the “tip of an iceberg”: a molecule optimizer utility that
can be used by medicinal chemists to optimize molecules
with regard to endpoints such as mutagenicity, CYP inhib-
ition, environmental toxicity, solubility and lipophilicity.
All utilities have been integrated into the Online Chemical
Modelling Environment and are freely available to the
academic community online at http://ochem.eu/.
Results and Discussion
In this section, we apply the prediction-driven matched
molecular pairs analysis for the QSAR models to the two
endpoints mentioned earlier: aquatic toxicity and
CYP3A4 inhibition. For each endpoint, we demonstrate
the additional knowledge gained from the prediction-
driven transformations and the practical value of such
knowledge for the molecular optimization procedure.
Significant transformations were defined as those with
a statistical significance of at least p <0.05. We used the
Holm-Bonferroni method [8] to reduce false positives
caused by the multiple comparisons problem. The statis-
tical significance (p-value) was calculated according to
formulae (1) and (2) described in the methodology
section. To avoid highly dissimilar matched pairs, we
considered only pairs of molecules with a Tanimoto
similarity of at least 50% calculated using ECFP finger-
prints [9] for the analysis.
Figure 2 Activity cliff example. A molecule inactive according to the Ames test becomes active after a minor structural change. Activity cliffs
represent interesting cases for activity interpretation.
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fied using experimental data as well as the prediction-
driven analysis is given in Table 1. After applying the
Holm-Bonferroni method, approximately half of the
transformations were discarded. Below, we provide a
detailed analysis of all endpoints and their respective
models.
The target molecules used as examples of transformation-
driven optimization are shown in Figure 3. These com-
prise several representative molecules from the DrugBank
database [10,11]. Some are marketed drugs, while others
are experimental molecules.
The results of the transformation-driven optimization
for each endpoint are described below.Aquatic toxicity model
In the optimization process, only significant transforma-
tions applicable to a particular molecule are used. It is
also often the case that a particular transformation can
be applied to a molecule in several different ways, result-
ing in multiple transformed molecules for each individ-
ual transformation.
Table 2 shows statistics for the aquatic toxicity
optimization using matched pairs.Table 1 The number of significant transformations






Aquatic toxicity 119 1552 5301
Ames test 132 442 4397
Clearly, prediction-based analysis provides significantly more transformations.The “generated” column gives the full number of prod-
uct molecules generated using the significant transfor-
mations. The “kept” column shows the number of those
molecules that passed the minimal similarity filter (50%
Tanimoto similarity to the original molecule). The “hits”
column gives the number of molecules for which the
transformation resulted (according to the model) in a
desired change of property, i.e. a reduction in aquatic
toxicity. The “effectiveness” column shows the hits-to-
kept ratio.
Each cell of the table contains two counts – the first
represents the number of molecules obtained from both
prediction-based and experiment-based transformations,
while the figure in brackets gives the count for
experimental-based transformations only.
It is apparent that prediction-driven transformations
provide significantly more hits than experimentally-
based ones. For example, prediction-based transforma-
tions provided more than 1,000 hits for the Permethrin
molecule, whereas experiment-based transformations
provided only 25. It is interesting that the effectiveness
of predicted transformations (percentage of hits among
all generated structures) is about the same as that of ex-
perimental ones.
Figure 4 shows several exemplary modifications of the
Permethrin molecule, obtained by applying significant
transformations.
It should be clearly stated that, although the suggested
structure modifications can be less toxic (as predicted by
a QSAR model), they can be unsatisfactory in other re-
spects: they can lose their primary effect (e.g. potency)
or become chemically infeasible or unstable. One poten-
tially unstable modification is highlighted in Figure 4.
It is also worth noting that reducing the toxicity of
Permethrin, an insecticide, may not be a desired effect
Figure 3 Molecules transformed within the scope of this study. All eight molecules were selected from the DrugBank database.
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strate the concept because of its high aquatic toxicity.
Figure 5 provides a visual representation of transfor-
mations applied to the Permethrin molecule. The trans-
formations identified as reducing toxicity in Permethrin
are replacements of several simple fragments or atoms
to a variety of other fragments. For example, the figure
highlights the replacement of an ether group by a dozen
other substituents.
Transformation amplification
As mentioned before, these transformations are derived
using predicted values. Some of the transformations were
among those identified using experimental data. However,
there were too few pairs to draw conclusions about the
statistical significance of a toxicity-reducing effect. For ex-
ample, Figure 6 shows the replacement of a hydrogenTable 2 The number of transformed molecules generated dur
Molecule Generated K
Permethrin 1217 (27) 8
Hexestrol 813 (10) 1
alpha-Naphthoflavone 583 (19) 1
Propidium 1812 (44) 1
Bithionol 224 (9) 9
Dequalinium 2095 (87) 1
Oxiconazole 1211 (25) 8
Lercanidipine 2059 (39) 1
For comparison, the number of molecules generated using only the transformationatom by a carboxyl group that has been identified as being
toxicity-reducing and which has been successfully used to
find non-toxic variants of Permethrin (left side of the
figure). This transformation had only four experimentally
measured pairs of molecules but has been “amplified”
using 362 predicted pairs of molecules (p-value <10−6).
Figure 7 gives a larger view of the “amplified” transfor-
mations. The blue dashed area shows the practically sig-
nificant transformations that are both:
 effective (resulting in a toxicity change of at least 1
log unit) and
 statistically significant (p-value <0.01 or less,
corresponding to a significance level of at least 2)
The black circles are the transformations based on
measured data. Only a few of such transformations areing aquatic toxicity optimization
ept Hits Effectiveness
91 (26) 854 (24) 96% (92%)
65 (8) 163 (8) 99% (100%)
36 (13) 132 (13) 97% (100%)
325 (37) 1316 (37) 99% (100%)
1 (8) 91 (8) 100% (100%)
645 (87) 1635 (87) 99% (100%)
26 (24) 798 (22) 97% (92%)
940 (39) 1928 (39) 99% (100%)
s based on experimental data is given in brackets.
Figure 4 Permethrin optimization examples. Six exemplary modifications of Permethrin that significantly decrease its predicted aquatic
toxicity (growth inhibition concentration). A decrease of 1–2 log units can be achieved by making only minor structural changes.
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gion of practical significance. The red circles show the
same transformations, which have been complemented
with the predicted data. The solid red circles show the
“amplified” transformations that were not significant but
became so after adding the predicted data.
Thus, prediction-driven MMP allows not only the dis-
covery of new transformations, but also the amplification
of existing ones by providing more evidence of the
observed effect. The same phenomenon is confirmed for
a classification property, CYP3A4 inhibition, in the ana-
lysis below.
CYP3A4 inhibition model
All of the selected molecules are CYP3A4 inhibitors of
different potencies. Therefore, we can use the MMP
optimization process to remove the CYP inhibition ac-
tivity from these molecules. Table 3 shows the results of
the optimization process.
We can see that the experimentally based transforma-
tions yielded very few hits, with effectiveness ranging
between 0% (no improvements found) and 73%. The
prediction-based transformations produced significantly
more hits and in most cases increased the effectiveness
compared to the experiment-based transformations.
The transformations graph shown in Figure 8 gives an
insight into the transformations applied to Hexestrol,
which was used as an example.We can see two clusters of transformations, which re-
duce the CYP3A4 inhibition activity in two different
approaches.
The cluster on the left represents replacement of one
of the benzene rings by a non-aromatic group, and the
cluster on the right mainly represents addition of a func-
tional group instead of a hydrogen or carbon. Figure 9
shows some of the molecules produced by the MMP
optimization process using these two approaches.
Clearly, the first approach is useless in most scenarios,
since it destroys the characteristic scaffold of the mol-
ecule. The resulting molecules may lose the main activ-
ity of the original molecule, which is inhibition of
microtubule polymerization [12].
The second approach produces more viable molecules
and in most cases tends to increase their solubility. As
we can see, addition of hydroxyl groups, acetic and
sulphonic acid groups and amine groups all reduce the
probability of a molecule being a CYP3A4 inhibitor.
Transformation amplification
Similar to the toxicity optimization example (Figure 6),
Figure 10 shows that an exemplary transformation that
was “inconclusive” according to the experimental data
(p-value 0.18 according to 22 sample pairs) was none-
theless found to reduce CYP inhibition in a statistically
significant sense according to the predicted data (p-value
0.01 according to 250 sample pairs). Thus, predictive-
Figure 5 Transformation graph for Permethrin optimization. Graph of the transformations that affect the aquatic toxicity of the Permethrin
molecule. The graph includes 393 transformations that provide replacements of several structural groups by less toxic variants. A cluster with
replacements of ether groups is shown in detail together with a few examples of optimized molecules.
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Figure 6 Experimental and predicted evidence supporting the toxicity-reducing effect of a selected transformation.
Figure 7 Toxicity optimization: statistically and practically significant transformations. The chart shows interesting transformations that
are both statistically significant (significance level >2, p-value <0.01) and effective (mean toxicity change at least one log unit). A number of
transformations that did not have sufficient measured pairs became significant when combined with predicted pairs (were “amplified”, shown as
solid red circles).
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Table 3 The number of product molecules generated
during CYP3A4 inhibition optimization
Molecule Generated Kept Hits Effectiveness
Permethrin 769 (101) 521 (86) 141 (9) 27% (10%)
Hexestrol 446 (39) 109 (11) 57 (8) 52% (73%)
alpha-Naphthoflavone 375 (64) 107 (23) 46 (7) 43% (30%)
Propidium 756 (110) 615 (96) 146 (1) 24% (1%)
Bithionol 103 (18) 39 (2) 19 (1) 49% (50%)
Dequalinium 519 (74) 487 (72) 96 (0) 20% (0%)
Oxiconazole 552 (73) 397 (47) 62 (0) 16% (0%)
Lercanidipine 1073 (148) 1037 (148) 175 (0) 17% (0%)
Sushko et al. Journal of Cheminformatics 2014, 6:48 Page 8 of 18
http://www.jcheminf.com/content/6/1/48driven MMP analysis allows not only identification of
new (predicted) transformations but also confirmation
of experimentally measured ones.
Figure 10 shows that predicted pairs allow us to draw
much stronger conclusions. In this example, 24 out of
25 inhibitors were “deactivated” and become non-
inhibitors after applying the analysed transformation.
None of the non-inhibitors became active. This shows
an effect that is significant both in a statistical and a
practical sense.
Similar to the toxicity use case, there are a number of
“amplified” transformations that were identified as both
statistically and practically significant after consideration
of predicted pairs. Such transformations are shown as
solid red circles in Figure 11.Figure 8 Transformations graph of CYP3A4 optimization of HexestrolThe “amplified” transformations are not identified using
exclusively the predicted data. Besides the predicted pairs,
there are “real”, experimentally measured pairs associated
with such transformations, which makes them more cred-
ible for a medicinal chemist.
The two use cases described above show that
prediction-driven MMP analysis allows the identifica-
tion of transformations that affect particular molecular
properties, so-called significant transformations. More-
over, such analyses identify more transformations than
classic experiment-based MMP analysis. This allows
the molecule optimization process to be improved –
more transformations result in more optimized struc-
tural suggestions.
The transformation graphs appeared to be a useful
tool for visualization of hundreds of transformations
and facilitating their interpretation. Thus, the graphs in
Figure 4 and Figure 8 allowed identifying the fragments
that tend to induce a particular activity (CYP inhibition,
aquatic toxicity or mutagenicity).
The detected MMP transformations can be also exported
and used in external applications, such as Molpher [13], to
optimize new chemical structures. They can be also used
as a part of discovery tools, such as the Self Organizing
Hypothesis Network (SOHN) [14], by enhancing the tool
with clearly interpretable knowledge units.
Several important points should be noted regarding
the limitations of transformation-driven molecular
optimization. We discuss these limitations and suggest
possible solutions below..
Figure 9 Sample modified molecules obtained from Hexestrol after CYP3A4 inhibition optimization. Overdestructive changes can be
avoided by additional filtering by structure similarity (e.g. Tanimoto similarity).
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The effect of a particular molecular transformation can
depend significantly on the context of the change. For
example, as illustrated in Figure 12, replacement of a
hydrogen atom by chlorine could have different effectsFigure 10 Experimental and predicted evidence supporting the CYP idepending on whether it is connected to an aromatic
ring or part of a reactive group.
The current implementation of MMP analysis ignores
the surrounding of the point of change and “averages” the
effects of a transformation for all possible contexts.nhibition-reducing effect of a selected transformation.
Figure 11 CYP inhibition optimization: statistically and practically significant transformations. The chart shows interesting transformations
that are both statistically significant (significance level >2, p-value <0.01) and effective (ratio of deactivated molecules at least 55%). A number of
transformations that did not have sufficient measured pairs became significant when combined with predicted pairs (were “amplified”, shown as
solid red circles).
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satisfactory results, it is suboptimal and, generally speak-
ing, it makes sense to distinguish transformations in dif-
ferent contexts. One approach is to prohibit the storing of
“small” transformations (e.g. by restricting the minimum
atom count in the fragment) and to accept only the larger
ones, which include more context information. Further-
more, expert knowledge in the form of a rule set can be
employed. Such sets of rules can, for instance, prevent
indexing of transformations that would destroy chemical
groups or aromatic ring systems.
Finally, the context problem can be addressed by using
chemistry-aware fragmentation algorithms, such as RECAP
[15]. Such fragmentation takes into account functionalFigure 12 Importance of chemical context for transformations. The samegroups; this makes it possible for example to distinguish an -
OH group (alcohol) and -OH as a part of a carboxylic acid.
Thus, the carboxyl group would be treated as a whole dur-
ing the MMP identification process.
In summary, the aforementioned approaches require
an elaborate definition of “acceptable” transformations
and improved fragmentation techniques. Such enhanced
indexing of molecular pairs could be a future improve-
ment of the methodology suggested here.
False positives
Not all “significant” transformations affect the molecule
in a desired way. For example, transformations can de-
crease toxicity for most molecules but increase it fortransformation can have significantly different effects in different contexts.
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“transformation effectiveness” (as specified in Tables 3
and 4) can be significantly less than 100%. Furthermore,
false positives may result from the multiple comparisons
problem, which is partially corrected by the Holm-
Bonferroni method. In either case, the problem of false
positives is not crucial, since the molecules without pre-
dicted improvements are explicitly filtered out.
Predictions
We use QSAR models both to identify transformations
and to evaluate whether they have the desired effect on
new chemicals. The predictions given by QSAR models
can be inaccurate, even considering the applicability do-
main estimates. This issue applies mostly to the purely
prediction-driven transformations that do not have suffi-
cient experimental evidence to confirm the predicted
effect (so-called “amplified” transformations). This issue
can be addressed either by gathering more experimental
data to confirm/discard the transformation effect or by
alerting users to the fact that the transformation is based
on predicted data. While implementation of the first
approach is open-ended, the latter approach is already
integrated into OCHEM. Namely, each transformation
has a profile page, where users can see whether the
transformation is based on experimental data, predicted
data or both.
Importantly, OCHEM comes with integrated applic-
ability domain assessment and can estimate the accuracy
of each prediction individually. Thus, the user is warned
of the risks and can choose to ignore potentially unreli-
able predictions.
Lost potency
The optimized structures may not possess useful proper-
ties of the original molecule. Thus, we may make a com-
pound less toxic but decrease its bioavailability or lose its
potency (e.g. binding affinity) altogether. This problem
can be addressed by multi-criterial optimization (e.g. using
the transformations that reduce toxicity but do not affect
lipophilicity) or, more universally, by post-filtering the op-
timized molecules by running QSAR models or estimating
their binding affinity using docking-derived techniques.
Chemical feasibility and stability
The suggested modifications can be unstable or difficult
(or infeasible) to synthesize. Assessment of feasibility andTable 4 Summary of the models used for prediction-
driven MMP analysis
Endpoint/Property Training set size Web-link
Aquatic toxicity 1 093 http://ochem.eu/model/3
CYP3A4 inhibition 15 316 http://ochem.eu/model/163stability can be incorporated as an additional filter to elim-
inate such structures. There are already many programs,
such as SYLVIA (http://www.molecular-networks.com/
products/sylvia) by Molecular Networks or REACTOR
(http://www.chemaxon.com/products/reactor/) by ChemAxon
that can be used for such purposes.
The assessment of feasibility is a different topic. In
general, chemical modifications and therefore reactions
can be described as feasible if they occur spontaneously
without an external source of energy. Such reactions are
therefore thermodynamically favourable. Hence, it is
common practice to filter such reactions using a set of
fixed rules that are meaningful from the synthesis point
of view [16]. There are a handful of computational tools
that identify these chemical sensible rules in a Retro-
synthetic analysis [17,18].
OCHEM was developed with flexibility and modularity
in mind. This is reflected in the ease of integration of
third-party utilities. Therefore, the tools for filtering out
unstable or infeasible compounds can be added as one
of the independent steps of the structure-optimization
process.
Complementing approaches
MMP analysis can be complemented by other interpret-
ation techniques. First, similarity maps [19] can visualize
differences between molecular structures. Such
visualization is not restricted to single-point changes as
with MMPs. Second, feature networks [20] can be used
to interpret individual predictions by identifying the acti-
vating and deactivating structural features. Finally, ap-
proaches that estimate the contributions of individual
fragments to the activity of interest [21] can be helpful
in confirming “significant” transformations. Integrating
such utilities into OCHEM could allow users to obtain a
comprehensive interpretation of predictions.
To summarize, if complemented by additional filtering
steps, prediction-driven MMPs and transformations are
useful for hit-to-lead optimization. Their public availabil-
ity will contribute to the widespread use of the computa-
tional chemistry [22] tools on the Web [23].
Conclusions
In this study, we investigated pairs of molecules that have
only minor localized differences in their structures – so-
called matched molecular pairs (MMPs). We suggested a
new concept of prediction-driven MMPs, utilizing predic-
tions given by QSARs for large chemical libraries to gener-
ate simple transformation rules that affect the activity of
interest (so-called “significant” transformations).
We saw clearly that such an approach generates add-
itional knowledge compared to classical MMP analysis.
We showed that, compared to traditional MMPs, which
are derived from experimental data only, predicted-driven
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the molecular optimization process by generating many
more suggestions for medicinal chemists.
Prediction accuracy and reliability were addressed by
incorporating the applicability domain of QSAR models
and the estimated prediction accuracy for each analysed
molecule.
The usefulness of the described methodology was ex-
emplified by two practical use cases. Two endpoints
were analysed: aquatic toxicity and CYP inhibition po-
tential. For both endpoints and their respective datasets,
we identified all MMPs and their respective molecular
transformations. A particular focus was on the identifi-
cation of “significant” transformations that reduced tox-
icity or CYP inhibition potential. These transformations
were identified using both experimental data and pre-
dicted data obtained using QSAR models applied to two
large chemical datasets with more than 400,000 com-
pounds. We showed that predicted data enabled identifi-
cation of a large number of significant transformations
and amplified the otherwise insignificant transforma-
tions useful in the molecule optimization process.
The approach developed here has limitations and
potential for improvement. To convert the suggested
methodology into a tool that could be used by medicinal
chemists, a number of questions still need to be an-
swered. These include: “How can we ensure that the
modified compounds are chemically feasible and stable?
How can we take the chemical context of the transfor-
mations into account? And how can we ensure that the
suggested structures do not lose the desired properties
of the original compounds (e.g. potency or drug-
likeness)?” The article included a discussion on the re-
quired improvements.
Importantly, all the methodological developments pre-
sented in this article have been implemented as a soft-
ware platform, which includes identification of MMPs,
extraction of rules (significant transformations), and in-
tegration with an online QSAR framework and chemical
database (OCHEM). The “tip of the iceberg” is the mo-
lecular optimization utility “MolOptimiser” which, with
a couple of mouse clicks, allows medicinal chemists to
optimize their molecules online using the knowledge
extracted from predictions of half a million compounds
by a dozen models.
The current implementation comes with a transforma-
tions database for a number of endpoints, such as muta-
genicity, aquatic toxicity, lipophilicity, solubility, melting
point and CYP inhibition. However, the database of rules
is expandable: users can upload their own datasets, build
QSAR models, identify significant transformations and
save them for further use.
Prediction-driven MMP analysis will help to open





In a broad sense, an MMP is defined as a pair of mole-
cules that differ by a minor single point change only.
The “minor single point” must be defined in specific
technical terms. In this study, we will consider a pair of
molecules a matched pair if the differing fragment is less
than 10 atoms in size and has fewer atoms than the un-
affected part of either molecule.
Molecular transformation
Each molecular pair is associated with a particular trans-
formation. An example transformation is the replacement
of one functional group by another. More specifically, we
define a transformation as a replacement of a molecular
fragment having one, two or three attachment points by
another fragment. Figure 13 shows two examples of mo-
lecular transformations with four corresponding molecu-
lar pairs each.
“Significant” transformations
One of the main ideas of MMP analysis is that some
molecular transformations tend to systematically affect
particular molecular properties. For example, a transform-
ation may systematically decrease toxicity or increase
lipophilicity of chemical compounds. We will label trans-
formations that affect a particular property/activity in a
statistically significant sense significant transformations.
A transformation is considered significant if it in-
creases the property value “more often” than it decreases
it, or vice versa. Thus, the distribution of increasing and
decreasing pairs should be significantly different from
the binomial (“no effect”) distribution with a particular
p-value (usually 0.05). More specifically, the p-value can
be calculated using Formula 1:
pValueregression¼ Prob ξ 0:5; Nð Þ≤ min npos; nneg
  
ð1Þ
where Prob stands for probability, npos and nneg are the
number of pairs that decreased and increased the prop-
erty, N is the total number of pairs, and ξ (0.5, N )is the bi-
nomial distribution with N trials and a probability of 0.5.
The mechanics of “statistical significance” are somewhat
different for binary classification properties, where a com-
pound is classified as either “active” or “inactive”. Such
properties include, for example, mutagenicity or CYP in-
hibition. For binary classification problems, we consider
the transformation as significant if the percentage of “ac-
tive” molecules in the analysed set is significantly changed
Figure 13 Exemplary molecular transformations. Single and double-point transformations shown.
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mial distribution of active as our “null hypothesis” and cal-
culate the p-value as follows:














where npos, nneg, ñpos and ñneg are the number of “active”
and “inactive” molecules in the sets before and after ap-
plying the transformation.
Visually, significant transformations can be described
by distributions of “pair deltas”, that is, by the difference
of the property values between the molecules in a
matched pair. Figure 14 shows a histogram of pair deltas
for the octanol/water partition coefficient and aquatic
toxicity for two simple transformations. The delta-pair
histograms were built using the data publicly available in
the OCHEM database.
Sometimes it is more convenient to use the signifi-
cance level, which is a log-scale representation of the p-
value calculated according to Formula 3. Thus, a p-value
of 0.01 corresponds to a significance level of “2”, while a
p-value of 0.001 corresponds to a significance level of
“3” and so on.significance level ¼ − log10 pValueð Þ ð3Þ
As many transformations are analysed, some transforma-
tions can pass the p-value threshold and be misclassified as
“significant” by mere chance. This phenomenon, known as
the “multiple comparisons” problem, can be partially ad-
dressed using the Holm-Bonferroni method [8].
Practical significance
In practice, it is important that the transformation effect
is not only statistically significant but also practically sig-
nificant in absolute terms. A transformation may be sta-
tistically significant but lead to a low absolute effect (e.g.
a toxicity reduction of 0.1 log unit). The practical signifi-
cance is defined for each endpoint individually and is
subjective.
For the purposes of this study, we will ignore the prac-
tical significance at the transformation identification
stage. Instead, we will consider it when using these
transformations in the molecular optimization process,
which is often the ultimate goal of the MMP analysis.
MMPs in the QSAR context
Here we describe a number of analytical methods that
allow us to interpret QSAR models using the MMP
approach.
Figure 14 Effect of a transformation on molecular properties. A) A simple transformation and the distribution of its effect on the octanol/
water partition coefficient. The histogram is visually biased to positive values: on average, this transformation increases lipophilicity. B)
Replacement of carbon by bromine significantly increases aquatic toxicity.
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In the MMP-related scientific literature, statistical ana-
lysis is usually performed using experimental data. One
of the major contributions of the current study is to use
predicted values in addition to experimental ones. This
approach gives two important advantages.
First, experimental data are often limited and do not
have sufficient measurements for a meaningful MMP-
based statistical analysis. Using predictions for large
datasets (e.g. compound libraries) allows us to overcome
the data limitation problem.
Second, using predicted values allows us to extract the
rules, based on the model’s point of view. We do not dir-
ectly analyse the data, rather we view it through the lens
of the model. This allows the analyst to interpret the
model itself rather than interpreting the available experi-
mental data.
Applicability domain
For any analysis based on predictions, it is of crucial
importance to consider the reliability of predictions and
to take into account the applicability domain (AD) of
the models [24,25]. The applicability domain of QSAR
models is a research field in itself and has received abun-
dant attention in the literature [26-28]. For this study,
we used the standard deviation (STD) of ensemble
predictions to define the applicability domain. This
was shown to be the most reliable approach for differ-
entiating accurate and inaccurate predictions and forestimating the prediction accuracy (the root mean
square error, RMSE, for classification models or the
correct prediction rate for classification models), as
described elsewhere [27,28].
The prediction accuracy is taken into account during
identification of “significant” transformations. Tech-
nically, we generate 1,000 replicas of the analysed
dataset by perturbing each prediction with an amount
of Gaussian noise with a magnitude (standard devi-
ation) depending on the estimated accuracy of the pre-
diction. Such a bootstrapping process is intended to
exclude transformations that are based on non-reliable
predictions.Transformations graph
Each molecular transformation is a replacement of
one molecular fragment by another; that is, a trans-
formation is a relation between two molecular frag-
ments. Based on the “significant” transformations, it is
possible to create a directed graph of molecular frag-
ments. Each node in the graph is a fragment, and each
edge a significant transformation. Such graphs can dis-
play a number of transformations and enable better
interpretation. The graph in Figure 15 shows a part of
the transformations related to Aquatic toxicity.
Compared to a simple list of significant transformations,
such a graph provides a more visual and interpretable
insight.
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MMPs can be used to identify subtle prediction behav-
iour, e.g. model reaction to activity cliffs. We define a
chart that shows the actual and predicted effects of mo-
lecular transformations a delta-pair chart. Such charts
can identify pairs that have a significant activity change,
referred to as activity cliffs. The chart in Figure 16 shows
the unaccounted and mispredicted activity cliffs, which
can help identify “weak points” in a model. The screen-
shot is based on an aquatic toxicity model [27] publicly
available at https://ochem.eu/model/3.
The points on the diagonal correspond to a perfect
match between the experimental and predicted effects of
a molecular transformation. Conversely, the points in
quadrants 2 and 4, (−, +) and (+, −), correspond to mis-
predicted activity cliffs. The larger number of points in
quadrants 1 and 3 indicates that the model has correctly
learned the majority of structure activity relationships
presented in the data.
Since the direction of an MMP transformation can be
arbitrarily changed, the position of points on the plot
can easily be flipped between quadrants 1 and 4 and be-
tween quadrants 2 and 3.Datasets and models
For the identification of matched pairs and molecular
transformations we used two chemical libraries, Chem-
Div and EINECS, described below.Figure 15 A transformations graph for aquatic toxicity. Arrows point t
that the presence of bromine is potentially more toxic than the presence o
this example.ChemDiv compound library
Chemical Diversity (ChemDiv) is a chemical provider
and contract research organization. It maintains and de-
velops several general purpose and targeted molecular
libraries for a variety of applications. In this study, we
used a chemically diverse ChemDiv library containing
391,145 molecules.
EINECS compound library
The EINECS (European INventory of Existing Commer-
cial chemical Substances) dataset comprises 68,779 unique
chemical compounds that are produced in or imported to
Europe in amounts of more than one ton per year. These
compounds are intended for the registration in REACH
program and, therefore, they are of particular interest for
the assessment of their environmental hazard.
To demonstrate the concept and methodology of
prediction-driven MMPs, we used the following two
QSAR/QSPR models, described below and summarized in
Table 4.
Aquatic toxicity model
This model [27] predicted the growth-inhibition concen-
trations measured on a ciliated protozoan Tetrahymena
pyriformis. This is an established screening tool for tox-
icity. The model was developed using E-state indices and
Associative Neural Networks [29] and produced one of
the highest accuracies in a benchmarking study to pre-
dict environmental toxicity [30].owards the direction of increasing toxicity. For example, it can be seen
f chlorine, whereas the hydroxyl group is the least toxic residual in
Figure 16 A delta-pair chart for an aquatic toxicity model. Three representative cases of activity cliffs are shown. The right part shows the
significant transformations for aquatic toxicity.
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The CYP model [31] was developed for inhibition of
Cytochromes P450 (CYP), a superfamily of enzymes
involved in the metabolism of a large number of xeno-
biotic compounds [32,33]. Over 75% of currently mar-
keted drugs are cleared with the help of CYP enzymes,
and almost half of these are metabolized by the CYP3A4
enzyme [34]. Inhibition of CYP3A4 may therefore lead to
toxicity by drug-drug interaction. This makes predictionFigure 17 A simplified database schema to store MMPs, transformatiof CYP3A4 enzyme inhibition one of the main goals in
early stage drug discovery.
In this study, we use a classification model, which as-
signs “inhibitor” and “non-inhibitor” labels to the pre-
dicted compounds. It was developed using a training set
of over 15,000 compounds obtained by high-throughput
screening [35]. The model was built using E-state indices
and ALogPS descriptors using Weka implementation of
J48 decision trees. Additionally, stratified bagging wasons and transformation annotations.
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All aforementioned MMP utilities have been tightly inte-
grated with the Online Chemical Modelling Environ-
ment (OCHEM, available at http://ochem.eu). OCHEM
is an online platform that allows scientists to perform
the full cycle of QSAR research, including:
 data collection, upload and management
 development of regression and classification QSAR
models with a dozen machine learning methods
 integration with more than 20 molecular descriptor
packages (both free and commercial)
 applicability domain assessment
 running predictions on published models for a
number of endpoints (Ames test, CYP inhibition,
Aquatic toxicity, Melting and Boiling points, Bio-
concentration factor, Fish toxicity and many more)
 a database of structural alerts with a screening
utility (the ToxAlerts module) [36]
A full list of OCHEM features can be found in the lit-
erature [22] or in the knowledge base [37].
The MMP utilities are tightly integrated with the
OCHEM user interface. The utilities can be summarized
briefly as follows: analysing MMPs for a dataset, identifica-
tion and saving significant transformations, constructing a
delta-pair chart for a model, drawing molecular fragment
transformation graphs, and searching for transformations
that affect multiple properties in a desired manner (“trans-
formation optimizer” utility). More detailed documenta-
tion and a user guide to MMPs in OCHEM can be found
online in the knowledge base [22,37].
Automatic indexation of MMPs
All molecules stored in OCHEM are automatically
screened for identification of MMPs. Technically, an
asynchronous background job fragments all the mole-
cules and creates an index as described in [6]. The frag-
mentation is performed on a distributed calculation
system provided by OCHEM. A second job uses this
index to identify MMPs, and create and update molecu-
lar transformations. OCHEM tracks the uniqueness of
molecules using InChi hash-keys [38,39] in order that
each unique molecule is processed only once.
An important consequence of the asynchronous index-
ing procedure is that new molecules are not available
immediately for MMP analysis but only after indexing,
which is usually a matter of a few hours.A simplified database schema for storing MMPs and
transformations is shown in Figure 17.
Technical limitations
To deal with the combinatorial explosion problem, only
molecules with 40 or fewer breakable bonds are consid-
ered for MMP indexing. Larger molecules are ignored.
The variable part of the molecule should have no more
than 10 atoms and fewer atoms than the main scaffold
of the molecule.
Technical statistics
Currently, the OCHEM database contains 700,000
indexed molecules, corresponding to about 12 million
matched molecular pairs categorized in ~500,000 unique
molecular transformations. The total size of the database
(excluding molecular structures) is 3 gigabytes.
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